 Some gynecomastia and breast tenderness developed in one patient treated with 50 mg/day, but significantly improved upon the dosage being halved.The observed tolerability profile of bicalutamide in these subjects has been regarded as significantly more favorable than that of analogues and estrogens (which are also used in the treatment of this condition).However, although successful and well tolerated, very few cases have been reported.